Stiles Financial Services Inc Buys 260 Shares of Intuitive Surgical, Inc. $ISRG

Stiles Financial Services Inc grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,099 shares of the medical equipment provider’s stock after acquiring an additional 260 shares during the period. Stiles Financial Services Inc’s holdings in Intuitive Surgical were worth $2,771,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Chilton Capital Management LLC raised its stake in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares in the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical in the first quarter worth approximately $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical in the first quarter worth approximately $30,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical in the first quarter worth approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $443.76 on Friday. The firm has a market capitalization of $159.08 billion, a PE ratio of 61.89, a price-to-earnings-growth ratio of 4.71 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company’s fifty day moving average price is $459.75 and its 200-day moving average price is $498.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period in the prior year, the company earned $1.78 earnings per share. The firm’s revenue was up 21.4% on a year-over-year basis. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently commented on ISRG shares. Truist Financial boosted their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. BTIG Research reaffirmed a “buy” rating and issued a $571.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 1st. Finally, Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 4th. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $589.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.